772 related articles for article (PubMed ID: 33692806)
1. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview.
Schinocca C; Rizzo C; Fasano S; Grasso G; La Barbera L; Ciccia F; Guggino G
Front Immunol; 2021; 12():637829. PubMed ID: 33692806
[TBL] [Abstract][Full Text] [Related]
2. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
Bunte K; Beikler T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
[TBL] [Abstract][Full Text] [Related]
3. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
Toussirot E
Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
[TBL] [Abstract][Full Text] [Related]
4. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.
Qu N; Xu M; Mizoguchi I; Furusawa J; Kaneko K; Watanabe K; Mizuguchi J; Itoh M; Kawakami Y; Yoshimoto T
Clin Dev Immunol; 2013; 2013():968549. PubMed ID: 23956763
[TBL] [Abstract][Full Text] [Related]
5. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases.
Navarro-Compán V; Puig L; Vidal S; Ramírez J; Llamas-Velasco M; Fernández-Carballido C; Almodóvar R; Pinto JA; Galíndez-Aguirregoikoa E; Zarco P; Joven B; Gratacós J; Juanola X; Blanco R; Arias-Santiago S; Sanz Sanz J; Queiro R; Cañete JD
Front Immunol; 2023; 14():1191782. PubMed ID: 37600764
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-23: a key cytokine in inflammatory diseases.
Duvallet E; Semerano L; Assier E; Falgarone G; Boissier MC
Ann Med; 2011 Nov; 43(7):503-11. PubMed ID: 21585245
[TBL] [Abstract][Full Text] [Related]
7. IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.
Li H; Tsokos GC
Clin Rev Allergy Immunol; 2021 Feb; 60(1):31-45. PubMed ID: 33185790
[TBL] [Abstract][Full Text] [Related]
8. The role of IL 23 in the treatment of psoriasis.
Puig L
Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
[TBL] [Abstract][Full Text] [Related]
9. The role of Th17 cells in psoriasis.
Li B; Huang L; Lv P; Li X; Liu G; Chen Y; Wang Z; Qian X; Shen Y; Li Y; Fang W
Immunol Res; 2020 Oct; 68(5):296-309. PubMed ID: 32827097
[TBL] [Abstract][Full Text] [Related]
10. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
[TBL] [Abstract][Full Text] [Related]
11. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
12. IL-17 in the rheumatologist's line of sight.
Truchetet ME; Mossalayi MD; Boniface K
Biomed Res Int; 2013; 2013():295132. PubMed ID: 23984335
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.
Chen S; Paveley R; Kraal L; Sritharan L; Stevens E; Dedi N; Shock A; Shaw S; Juarez M; Yeremenko N; Baeten D; Payne A
J Autoimmun; 2020 Jul; 111():102435. PubMed ID: 32360069
[TBL] [Abstract][Full Text] [Related]
14. Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis.
McGonagle D; Watad A; Sharif K; Bridgewood C
Front Immunol; 2021; 12():614255. PubMed ID: 33815371
[TBL] [Abstract][Full Text] [Related]
15. The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases.
Sherlock JP; Taylor PC; Buckley CD
Curr Opin Rheumatol; 2015 Jan; 27(1):71-5. PubMed ID: 25415528
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
van Hamburg JP; Tas SW
J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
[TBL] [Abstract][Full Text] [Related]
17. The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis.
Tsukazaki H; Kaito T
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899140
[TBL] [Abstract][Full Text] [Related]
18. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
[TBL] [Abstract][Full Text] [Related]
20. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.
Raychaudhuri SK; Saxena A; Raychaudhuri SP
Clin Rheumatol; 2015 Jun; 34(6):1019-23. PubMed ID: 25939522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
